Dugan Selkirk

Universal Ibogaine Announces Kelburn Reopening Date

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – TheNewswire – September 22, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s research and development clinic, the Kelburn Mental Health and Addiction Recovery Center is scheduled to reopen and commence business operations on October 17, 2022 . Dr Universal Ibogaine Announces Kelburn Reopening Date

Universal Ibogaine appoints Nick Karos to the Board of Directors

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – September 6, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has appointed Nicholas (“Nick”) Karos, CEO of the Company, to its Board of Directors of UI effective September 6, 2022.  UI will hold its Universal Ibogaine appoints Nick Karos to the Board of Directors

Universal Ibogaine Provides Update on Kelburn Recovery Center

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – August 19, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) is a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care. Ibogaine is a plant derived medicine used in addiction treatment and has been shown to deliver detoxification from opioids, heroin and other substances, and can provide Universal Ibogaine Provides Update on Kelburn Recovery Center

Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – TheNewswire – June 24, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment using medicalized ibogaine and a global licensing model is pleased to announce that Nick Karos, CEO will present at the H.C. Wainwright 1 st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond.  The event Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference

Universal Ibogaine Engages Investor Relations Firm Blue Digital Media

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – TheNewswire – June 13, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model advises it has engaged investor communications firm Blue Digital Media & Web Solutions (“ Blue Digital ”) for assistance with expanding awareness of Universal Ibogaine Engages Investor Relations Firm Blue Digital Media

Universal Ibogaine Advises Departure of David Danziger from Board of Directors

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – TheNewswire – June 10, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that David Danziger has resigned as a member of the UI Board of Directors. UI thanks David for his contributions to the Company during Universal Ibogaine Advises Departure of David Danziger from Board of Directors

Universal Ibogaine Co-Founder Dr. Alberto Sola to Present at Research to Reality Conference

Universal Ibogaine Provides Update on Kelburn Recovery Center

CALGARY, AB , May 13, 2022 /PRNewswire/ – Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) (” UI ” or the ” Company “) a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model is pleased to announce that UI Co-Founder Dr Alberto Sola will present at the May 27 to 29 event: From Universal Ibogaine Co-Founder Dr. Alberto Sola to Present at Research to Reality Conference

Universal Ibogaine Retains Shayne Nyquvest as Capital Markets Advisor

Universal Ibogaine Provides Update on Kelburn Recovery Center

CALGARY, AB , April 29, 2022 /CNW/ – Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) (” UI ” or the ” Company “) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that it has retained Mr. Shayne Nyquvest in a consulting role as Capital Markets Advisor. Mr. Nyquvest has extensive capital markets experience, with Universal Ibogaine Retains Shayne Nyquvest as Capital Markets Advisor

Universal Ibogaine Advises of Departure of Marilyn Mauritz from Board of Directors

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – April 21, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that Marilyn Loewen Mauritz has resigned as a member of the UI Board of Directors to pursue other opportunities.  The Board of Directors would Universal Ibogaine Advises of Departure of Marilyn Mauritz from Board of Directors

Universal Ibogaine Provides Update on Kelburn Recovery Center Operations

Universal Ibogaine Provides Update on Kelburn Recovery Center

Calgary, AB – April 7, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that it has temporarily closed the Kelburn Recovery Centre (“Kelburn”) due to an on-site flooding issue.  Kelburn is UI’s addiction treatment site operating near Universal Ibogaine Provides Update on Kelburn Recovery Center Operations